Cargando…
Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promotes oligodendrocyte-mediated remyelination
Multiple sclerosis (MS) is characterized by autoimmune damage to the central nervous system. All the current drugs for MS target the immune system. Although effective in reducing new lesions, they have limited effects in preventing the progression of disability. Promoting oligodendrocyte-mediated re...
Autores principales: | Du, Changsheng, Duan, Yanhui, Wei, Wei, Cai, Yingying, Chai, Hui, Lv, Jie, Du, Xiling, Zhu, Jian, Xie, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822006/ https://www.ncbi.nlm.nih.gov/pubmed/27040771 http://dx.doi.org/10.1038/ncomms11120 |
Ejemplares similares
-
Promotion of microglial phagocytosis by tuftsin stimulates remyelination in experimental autoimmune encephalomyelitis
por: Bao, Zheng, et al.
Publicado: (2019) -
The Antiepileptic Drug Valproic Acid Restores T Cell Homeostasis and Ameliorates Pathogenesis of Experimental Autoimmune Encephalomyelitis
por: Lv, Jie, et al.
Publicado: (2012) -
Molecular Mechanisms of Oligodendrocyte Injury in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
por: Patel, Jilpa, et al.
Publicado: (2012) -
Fibrotic scar after experimental autoimmune encephalomyelitis inhibits oligodendrocyte differentiation
por: Yahn, Stephanie L., et al.
Publicado: (2019) -
18β-glycyrrhetinic acid suppresses experimental autoimmune encephalomyelitis through inhibition of microglia activation and promotion of remyelination
por: Zhou, Jieru, et al.
Publicado: (2015)